Naoko Matsunaga

机构：Scripps Research Institute, California Institute for Biomedical Research · ORCID：0000-0002-8529-5199

发表论文 47 篇 · 总被引 3006 次 · h-index 16

代表论文

• Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (2020 · Nature · 被引 864)
• TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules (2010 · Molecular Pharmacology · 被引 606)
• A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling (2005 · Molecular Pharmacology · 被引 384)
• Analysis of binding site for the novel small‐molecule TLR4 signal transduction inhibitor TAK‐242 and its therapeutic effect on mouse sepsis model (2009 · British Journal of Pharmacology · 被引 250)
• Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 (2021 · Nature · 被引 215)
• Possible involvement of proteolytic degradation of tyrosinase in the regulatory effect of fatty acids on melanogenesis (1999 · Journal of Lipid Research · 被引 143)